Previous 10 |
home / stock / phguf / phguf news
Pharming Group NV (PHGUF) Q2 2019 Earnings Conference Call July 25, 2019 7:00 am ET Corporate Participants Sijmen De Vries - Chief Executive Officer Robin Wright - Chief Financial Officer Conference Call Participants Simon Scholes - First Berlin Christian Glennie - Stifel ...
Delivered 31% increase in revenue, 51% increase in operating profit and 60% increase in net profit year-on-year Delivered 21% increase in revenue, with increases in operating profit and net profit compared to Q1 2019 Increased investment in pipeline to support long-term growth L...
Pharming Group N.V. ( OTCPK:PHGUF ): 1H GAAP EPS of €0.020. More news on: Pharming Group N.V., Earnings news and commentary, Healthcare stocks news, Read more ...
The following slide deck was published by Pharming Group NV in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Pharming Group Nv Ord Company Name:
PHGUF Stock Symbol:
OTCMKTS Market:
Pharming Group Nv Ord Website:
Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) second quarter and first half 2024 financial results, for the period ended June 30, on Thursday, August 1, 2024. ...
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of June: Jefferies Healthcare Conference, New ...
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved. The shareholders approved the proposa...